Impact of distinct chemical structures for the development of a methamphetamine vaccine

Journal of the American Chemical Society

Volumn 133, Issue 17, 2011, Pages 6587-6595

  Moreno, Amira Y ^a   Mayorov, Alexander V ^a   Janda, Kim D ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY AFFINITY; ANTIBODY TITERS; AROMATIC RINGS; BLOOD-BRAIN BARRIER; CHEMICAL STRUCTURE; DRUG PENETRATION; HIGH AFFINITY; IMMUNE RECOGNITION; IMMUNOPHARMACOTHERAPY; PHARMACOTHERAPIES; TARGET STRUCTURE;

ANTIBODIES; ANTIGENS; VACCINES;

STRUCTURAL DESIGN;

HAPTEN; METHAMPHETAMINE; METHAMPHETAMINE VACCINE; MH2 VACCINE; MH6 VACCINE; MH7 VACCINE; UNCLASSIFIED DRUG; VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG DEPENDENCE; DRUG SYNTHESIS; IMMUNIZATION; MOUSE; NONHUMAN;

ANIMALS; ANTIBODIES; CENTRAL NERVOUS SYSTEM STIMULANTS; HAPTENS; IMMUNOCONJUGATES; METHAMPHETAMINE; MICE; MODELS, MOLECULAR; SUBSTANCE-RELATED DISORDERS; VACCINATION; VACCINES;

EID: 79955399425     PISSN: 00027863     EISSN: 15205126     Source Type: Journal    
DOI: 10.1021/ja108807j     Document Type: Article

References (35)

1. Gonzales, R.; Mooney, L.; Rawson, R. A. The Methamphetamine Problem in the United States Annu. Rev. Public Health 2010, 31, 385-98
2. Nicosia, N.; Pacula, R. L.; Kilmer, B.; Lundberg, R.; Chiesa, J. The Economic Cost of Methamphetamine Use in the United States, 2005; RAND Corporation: Santa Monica, CA, 2009. http://www.rand.org/pubs/monographs/MG829.
3. Treweek, J. B.; Dickerson, T. J.; Janda, K. D. Drugs of Abuse That Mediate Advanced Glycation End Product Formation: A Chemical Link to Disease Pathology Acc. Chem. Res. 2009, 42 (5) 659-669
4. Meijler, M. M.; Matsushita, M.; Wirsching, P.; Janda, K. D. Development of Immunopharmacotherapy Against Drugs of Abuse Curr. Drug Discovery Technol. 2004, 1 (1) 77-89
5. Karila, L.; Weinstein, A.; Aubin, H.-J.; Benyamina, A.; Reynaud, M.; Batki, S. L. Pharmacological approaches to methamphetamine dependence: a focused review Br. J. Clin. Pharmacol. 2010, 69 (6) 578-592
6. Kantak, K. M. Vaccines against drugs of abuse: A viable treatment option? Drugs 2003, 341-352 (Pubitemid 36259522)
7. Meijler, M.; Matsushita, M.; Wirsching, P.; Janda, K. D. Development of Immunopharmacotherapy Against Drugs of Abuse Curr. Drug Discovery Technol. 2004, 1, 77-89
8. Kosten, T.; Owens, S. M. Immunotherapy for the treatment of drug abuse Pharmacol. Ther. 2005, 108 (1) 76-85 (Pubitemid 41377120)
9. Cornuz, J.; Zwahlen, S.; Jungi, W. F.; Osterwalder, J.; Klingler, K.; van Melle, G.; Bangala, Y.; Guessous, I.; Muller, P.; Willers, J.; Maurer, P.; Bachmann, M. F.; Cerny, T. A Vaccine against Nicotine for Smoking Cessation: A Randomized Controlled Trial PLoS ONE 2008, 3 (6) e2547
10. Hatsukami, D. K.; Rennard, S.; Jorenby, D.; Fiore, M.; Koopmeiners, J.; de Vos, A.; Horwith, G.; Pentel, P. R. Safety and immunogenicity of a nicotine conjugate vaccine in current smokers Clin. Pharmacol. Ther. 2005, 78 (5) 456-467 (Pubitemid 41698900)
11. Haney, M.; Gunderson, E. W.; Jiang, H.; Collins, E. D.; Foltin, R. W. Cocaine-specific antibodies blunt the subjective effects of smoke cocaine in humans Biol. Psychiatry 2010, 67 (1) 59-65
12. Martell, B. A.; Orson, F. M.; Poling, J.; Mitchell, E.; Rossen, R. D.; Gardner, T.; Kosten, T. R. Cocaine vaccine for the treament of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial Arch. Gen. Psychiatry 2009, 66 (10) 1116-1123
13. Byrnes-Blake, K. A.; Carroll, F. I.; Abraham, P.; Owens, S. M. Generation of anti-(+)methamphetmaine antibodies is not impeded by (+)methamphetamine administration during active immunization of rats Int. Immunopharmacol. 2001, 1, 329-338 (Pubitemid 32183731)
14. Ino, A.; Dickerson, T. J.; Janda, K. D. Positional linker effects in haptens for cocaine immunopharmacotherapy Bioorg. Med. Chem. Lett. 2007, 17 (15) 4115-4121
15. Owens, S. M.; Zorbas, M.; Lattin, D. L.; Gunnell, M.; Polk, M. Antibodies against arylcyclohexylamines and their similarities in binding specificity with the phencyclidine receptor J. Pharmacol. Exp. Ther. 1988, 246 (2) 472-478
16. Matsushita, M.; Hoffman, T. Z.; Ashley, J. A.; Zhou, B.; Wirsching, P.; Janda, K. D. Cocaine catalytic antibodies: the primary importance of linker effects Bioorg. Med. Chem. Lett. 2001, 11 (2) 87-90 (Pubitemid 32099616)
17. Peterson, E. C.; Gunnell, M.; Che, Y.; Goforth, R. L.; Carroll, F. I.; Henry, R.; Liu, H.; Owens, S. M. Using Hapten Design to Discover Therapeutic Monoclonal Antibodies for Treating Methamphetamine Abuse J. Pharmacol. Exp. Ther. 2007, 322, 30-39 (Pubitemid 46956367)
18. Duryee, M. J.; Bevins, R. A.; Reichel, C. M.; Murray, J. E.; Dong, Y.; Thiele, G. M.; Sanderson, S. D. Immune response to methamphetamine by active immunization with peptide-based, molecular adjuvant-containing vaccines Vaccine 2009, 27, 2981-2988
19. Gentry, W. B.; Ruedi-Bettschen, D.; Owens, S. M. Development of active and passive human vaccines to treat methamphetamine addiction Hum. Vaccines 2009, 5 (4) 206-213
20. Kaminski, G. A.; Friesner, R. A.; Tirado-Rives, J.; Jorgensen, W. L. Evaluation and Reparametrization of the OPLS-AA Force Field for Proteins via Comparison with Accurate Quantum Chemical Calculations on Peptides J. Phys. Chem. B 2001, 105, 6474-6487 (Pubitemid 35339015)
21. Still, W. C.; Tempczyk, A.; Hawlely, R. C.; Hendrickson, T. A. General Treatment of Solvation for Molecular Mechanics J. Am. Chem. Soc. 1990, 112, 6127-6129
22. Kolossváry, I.; Guida, W. C. Low-mode Conformational Search Elucidated. Application to C39H80 and Flexible Docking of 9-Deazaguanine Inhibitors to PNP J. Comput. Chem. 1999, 20, 1671
23. David, R. L. Handbook of Chemistry and Physics, 90 th ed.; CRC Press: New York, NY, 2009-2010; p 2804.
24. Huizing, G.; Beckett, A. Physico-chemical aspects of metabolically induced changes at the basic centre of two anti-emetics; relationship with in vivo membrane penetration Pharm. World Sci. 1980, 2 (1) 253-261
25. Beaumont, D.; Waigh, R. D.; Sunbhanich, M.; Nott, M. W. Synthesis of 1-(aminomethyl)-1,2,3,4-tetrahydroisoquinolines and their actions at adrenoceptors in vivo and in vitro J. Med. Chem. 1983, 26 (4) 507-515 (Pubitemid 13162293)
26. a prediction and protonation state generation for drug-like molecules J. Comput.-Aided Mol. Des. 2007, 21 (12) 681-691
27. Meijler, M. M.; Matsushita, H.; Atobell, L. J.; Wirshing, P.; Janda, K. D. A new strategy for improved nicotine vaccines using conformationally constrained haptens J. Am. Chem. Soc. 2003, 125, 7164-7165 (Pubitemid 36798951)
28. Dewey, S. L.; Kroll, C.; Ferrieri, R.; Schiffer, W.; Alexoff, D.; Shea, D.; Youwen, C. X.; Muench, L.; Volkow, L.; Fowler, J. PET studies of methamphetamine enantiomers. J. Nucl. Med. Meeting Abstr. 2006, 47, 135P-b.
29. Mendelson, J.; Uemura, N.; Harris, D.; Nath, R.; Fernandez, E.; Jacob, P. I.; Everhart, E. T.; Jones, R. T. Human pharmacology of the methamphetamine stereoisomers Clin. Pharmacol. Ther. 2006, 80 (4) 403-420 (Pubitemid 44479752)
30. Wang, Z.; Woolverton, W. L. Estimating the relative reinforcing strength of (±)-3,4-methylenedioxymethamphetamine (MDMA) and its isomers in rhesus monkeys: comparison to (+)-methamphetamine Psychopharmacology 2007, 189 (4) 483-488 (Pubitemid 44791218)
31. Janda, K. D.; Benkovic, S. J.; Lerner, R. A. Catalytic Antibodies with Lipase Activity and R and S Substrate Selectivity Science 1989, 244, 437-440 (Pubitemid 19127501)
32. Laurenzana, E. M.; Hendrickson, H. P.; Carpenter, D.; Peterson, E. C.; Gentry, W. B.; West, M.; Che, Y.; Carroll, F. I.; Owens, S. M. Functional and biological determinants affecting the duration of action and efficacy of anti-(+)-methamphetamine monoclonal antibodies in rats Vaccine 2009, 27 (50) 7011-7020
33. Keyler, D. E.; Roiko, S. A.; Earley, C. A.; Murtaugh, M. P.; Pentel, P. R. Enhanced immunogenicity of a bivalent nicotine vaccine Int. Immunopharmacol. 2008, 8, 1589-1594
34. Carroll, F. I.; Abraham, P.; Gong, P. K.; Pidaparthi, R. R.; Blough, B. E.; Che, Y.; Hampton, A.; Gunnell, M.; Lay, J. O., Jr.; Peterson, E. C.; Owens, S. M. The synthesis of haptens and their use for the development of monoclonal antibodies for treating methamphetamine abuse J. Med. Chem. 2009, 52 (22) 7301-9
35. Muller, R. Determination of affinity and specificity of anti-hapten antibodies by competitive radioimmunoassay Methods Enzymol. 1983, 92, 589-601 (Pubitemid 14004096)